www.finanznachrichten.de · · DE
68592954 compass pathfinder limited compass pathways to participate in jefferies global healthcare conference on june 3 2026 004

Topic context
This topic has been covered 176856 times in the last 7 days across our monitored publishers.
The full article is on the original publisher site.
AI insight
AI-generatedThis is a routine investor conference participation with no new commercial data. No product price, supply chain, or margin impact is disclosed. The event may provide updates on clinical progress but no concrete commercial mechanism is triggered.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Compass Pathways (CMPS) to present at Jefferies Global Healthcare Conference on June 3, 2026.
- COMP360 synthetic psilocybin has FDA Breakthrough Therapy designation for treatment-resistant depression.
- COMP360 also has UK Innovative Licensing and Access Pathway designation.
- Company is headquartered in London with an office in New York.
Related stories

manilatimes.net
Auddia Reports Strong Artist and Industry Response to Discovr Radios Toronto Debut at Departure Festival Conference Identifies City as Key Growth Hub

kashmirlife.net
How Did Kashmiri Pilgrims Undertake the Hajj Journey in Earlier Times
prnewswire.com
Intu Notification Intuit Pricing Issues and Corresponding 20 Stock Drop Trigger Shareholder Investigation for Securities Fraud
nyasatimes.com
Before the Mines Run Dry the Urgent Case for Malawis Sovereign Wealth Fund

euobserver.com